CD248 and sarcoma: TEM1 has so far been thought of as a promising molecular target for sarcoma; however, the present study showed the possibility that TEM1 inhibition might represent a new therapeutic strategy through the targeting of TEM1 expression in the CAFs of gastric carcinoma.